Imerys (NK) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
30 Jul, 2026Executive summary
H1 2026 revenue reached €1.74 billion, up 1.8% at constant exchange rates, driven by higher sales volumes despite subdued demand in some end markets.
Adjusted EBITDA grew 10% year-over-year at constant exchange rates to €290 million, with margin improving to 16.6%.
Net current free operating cash flow rose to €109 million, reflecting improved profitability, lower capex, and disciplined working capital management.
Strategic roadmap advanced with Project Horizon delivering €17 million in savings by June 2026 and completion of key acquisitions in the US (Great Lakes Minerals) and Brazil (SB Mineração).
Net income, Group share, was €49 million, down from €70 million in H1 2025, impacted by restructuring costs and one-off items.
Financial highlights
Q2 2026 revenue was €906 million, up 2.9% at constant exchange rates; H1 2026 revenue: €1.74 billion (+1.8% at constant FX).
Adjusted EBITDA: €290 million in H1 2026 (+10% year-over-year at constant FX); margin improved to 16.6%.
Net financial debt at June 30, 2026: €1,468 million, up €77 million from December 2025, mainly due to acquisitions and lease adjustments.
Net current free operating cash flow: €109 million in H1 2026.
Net income per share: €0.78, down from €0.98 in H1 2025.
Outlook and guidance
Full-year 2026 adjusted EBITDA targeted at €550–580 million, assuming no major macroeconomic or geopolitical deterioration.
Management remains focused on cost control, cash discipline, and strategic execution amid ongoing market uncertainties.
Guidance reflects caution due to energy price volatility, inflation risk, and potential interest rate hikes.
Latest events from Imerys
- Solid organic growth, margin expansion, and strong ESG progress despite non-cash net loss.NK
H2 20249 Jul 2026 - All resolutions passed, with strong 2024 results, higher dividend, and strategic progress.NK
AGM 20258 Jul 2026 - All resolutions passed, with stable financials, new board members, and key strategic initiatives advanced.NK
AGM 20268 Jul 2026 - H1 2024 adjusted EBITDA rose 11% to €384 million, margin 20%, with strong net income growth.NK
H1 20248 Jul 2026 - Q1 2026 saw modest growth and margin gains, offset by FX and restructuring impacts.NK
Q1 202629 Apr 2026 - Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 202520 Feb 2026 - Nine-month EBITDA margin rose to 19.2% as full-year guidance is confirmed.NK
Q3 202417 Jan 2026 - Organic growth and sustainability progress offset margin pressure from joint venture declines.NK
Q1 202524 Dec 2025 - Stable H1 2025 sales and EBITDA, but net income fell; full-year EBITDA guidance reaffirmed.NK
Q2 202516 Nov 2025